NYVEPRIA: Package Insert and Label Information (Page 3 of 3)

PRINCIPAL DISPLAY PANEL — 6 mg/0.6 mL Syringe Label

Nyvepria™
(pegfilgrastim-apgf) Injection

Rx only

6 mg/0.6 mL

For Subcutaneous Use Only
Single-Dose Prefilled Syringe
with Needle Guard

NDC 0069-0324-01
Mfd by Hospira, Inc., a Pfizer
Company Lake Forest, IL 60045 USAUS License No. 1974

PAA147907

PRINCIPAL DISPLAY PANEL -- 6 mg/0.6 mL Syringe Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 6 mg/0.6 mL Syringe Carton — PAA185776

Nyvepria™
(pegfilgrastim-apgf) Injection

6 mg/0.6 mL

For Subcutaneous Use Only
Sterile Solution — No Preservative

1 x 6 mg/0.6 mL
Single-Dose Prefilled Syringe
with Needle Guard

Pegylated Recombinant Methionyl Human
Granulocyte Colony-Stimulating Factor(PEG-r-metHuG-CSF) derived from E coli

NDC 0069-0324-01

Rx Only

PRINCIPAL DISPLAY PANEL -- 6 mg/0.6 mL Syringe Carton -- PAA185776
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 6 mg/0.6 mL Syringe Carton — PAA185777

Nyvepria™
(pegfilgrastim-apgf) Injection

6 mg/0.6 mL

For Subcutaneous Use Only
Sterile Solution — No Preservative

1 x 6 mg/0.6 mL Single-Dose
Prefilled Syringe with Needle Guard

Pegylated Recombinant Methionyl Human
Granulocyte Colony-Stimulating Factor(PEG-r-metHuG-CSF) derived from E coli

NDC 0069-0324-01

Rx Only

PRINCIPAL DISPLAY PANEL -- 6 mg/0.6 mL Syringe Carton -- PAA185777
(click image for full-size original)
NYVEPRIA pegfilgrastim-apgf injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0069-0324
Route of Administration SUBCUTANEOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PEGFILGRASTIM (PEGFILGRASTIM) PEGFILGRASTIM 6 mg in 0.6 mL
Inactive Ingredients
Ingredient Name Strength
ACETIC ACID
POLYSORBATE 20
SODIUM ACETATE
SORBITOL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0069-0324-01 1 CARTON in 1 CARTON contains a CARTON
1 1 SYRINGE in 1 CARTON This package is contained within the CARTON (0069-0324-01) and contains a SYRINGE
1 0.6 mL in 1 SYRINGE This package is contained within a CARTON and a CARTON (0069-0324-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA761111 12/15/2020
Labeler — Pfizer Laboratories Div Pfizer Inc (134489525)
Establishment
Name Address ID/FEI Operations
Hospira Zagreb d.o.o. 500625201 ANALYSIS (0069-0324), MANUFACTURE (0069-0324), API MANUFACTURE (0069-0324), PACK (0069-0324), LABEL (0069-0324)
Establishment
Name Address ID/FEI Operations
Pfizer Inc 004954111 ANALYSIS (0069-0324)

Revised: 03/2023 Pfizer Laboratories Div Pfizer Inc

Page 3 of 3 1 2 3

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.